U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


RAKIN KEVIN (0001184421)
Mailing Address
36 CHURCH LANE
WESTPORT CT 06880
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
AZIYO BIOLOGICS, INC.
Current Name:ELUTIA INC.		 0001708527 2020-10-07 director, 10 percent owner
HighCape Capital Acquisition Corp.
Current Name:Quantum-Si Inc		 0001816431 2020-09-03 director, officer: Chairman and CEO
HISTOGENICS CORP
Current Name:Ocugen, Inc.		 0001372299 2016-09-29 director
Integrated Security Technologies, Inc.
Current Name:ORAMED PHARMACEUTICALS INC.		 0001176309 2016-08-30 director
Omrix Biopharmaceuticals, Inc. 0001349426 2007-01-16 director
VION PHARMACEUTICALS INC 0000944522 2007-01-15 director
CLINICAL DATA INC 0000716646 2006-05-12 director
GENAISSANCE PHARMACEUTICALS INC 0001110009 2003-12-09 director, officer: Pres. and CEO


Items 1 - 80

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2024-06-06   ELUTIA INC. 4 A-Award --D 47753.0000 47753.0000 1 0001708527 Stock Option (Right to Buy)
A 2024-05-16   Quantum-Si Inc 4 A-Award --D 113281.0000 113281.0000 1 0001816431 Stock Option (right to buy)
A 2023-05-12   Quantum-Si Inc 4 A-Award --D 120481.0000 120481.0000 1 0001816431 Stock Option (right to buy)
D 2022-12-20   Quantum-Si Inc 4 J-Other --I 601000.0000 1200000.0000 1 0001816431 Class A Common Stock
D 2022-12-15   Quantum-Si Inc 4 S-Sale --I 89000.0000 1801000.0000 1 0001816431 Class A Common Stock
A 2022-05-11   Quantum-Si Inc 4 A-Award --D 59880.0000 59880.0000 1 0001816431 Stock Option (right to buy)
D 2022-03-21   ORAMED PHARMACEUTICALS INC. 4 S-Sale --D 10000.0000 46661.0000 1 0001176309 Common Stock
D 2022-02-17   ORAMED PHARMACEUTICALS INC. 4 M-Exempt --D 6667.0000 0.0000 3 0001176309 Stock Option (right to buy)
D 2022-02-17   ORAMED PHARMACEUTICALS INC. 4 F-InKind --D 3010.0000 56661.0000 2 0001176309 Common Stock
A 2022-02-17   ORAMED PHARMACEUTICALS INC. 4 M-Exempt --D 6667.0000 59671.0000 1 0001176309 Common Stock
D 2022-02-11   ORAMED PHARMACEUTICALS INC. 4/A G-Gift -ED 5000.0000 53004.0000 1 0001176309 Common Stock
D 2022-02-11   ORAMED PHARMACEUTICALS INC. 4 G-Gift -ED 5000.0000 47004.0000 1 0001176309 Common Stock
A 2022-01-03   ORAMED PHARMACEUTICALS INC. 4 A-Award --D 10000.0000 10000.0000 2 0001176309 Stock Option (right to buy)
A 2022-01-03   ORAMED PHARMACEUTICALS INC. 4 A-Award --D 6000.0000 58004.0000 1 0001176309 Common Stock
D 2021-12-16   ORAMED PHARMACEUTICALS INC. 4 G-Gift -ED 5000.0000 52004.0000 1 0001176309 Common Stock
D 2021-11-03   Quantum-Si Inc 5 G-Gift --I 11000.0000 1890000.0000 1 0001816431 Class A Common Stock
D 2021-09-16   ORAMED PHARMACEUTICALS INC. 4 S-Sale --D 21100.0000 57004.0000 1 0001176309 Common Stock
A 2021-08-31   ORAMED PHARMACEUTICALS INC. 4 A-Award --D 10000.0000 78104.0000 1 0001176309 Common Stock
D 2021-08-09   ORAMED PHARMACEUTICALS INC. 4 M-Exempt --D 56773.0000 0.0000 12 0001176309 Stock Option (right to buy)
D 2021-08-09   ORAMED PHARMACEUTICALS INC. 4 M-Exempt --D 10000.0000 0.0000 11 0001176309 Stock Option (right to buy)
D 2021-08-09   ORAMED PHARMACEUTICALS INC. 4 M-Exempt --D 6666.0000 0.0000 10 0001176309 Stock Option (right to buy)
D 2021-08-09   ORAMED PHARMACEUTICALS INC. 4 M-Exempt --D 5697.0000 0.0000 9 0001176309 Stock Option (right to buy)
D 2021-08-09   ORAMED PHARMACEUTICALS INC. 4 F-InKind --D 20916.0000 68104.0000 8 0001176309 Common Stock
A 2021-08-09   ORAMED PHARMACEUTICALS INC. 4 M-Exempt --D 56773.0000 89020.0000 7 0001176309 Common Stock
D 2021-08-09   ORAMED PHARMACEUTICALS INC. 4 F-InKind --D 1977.0000 32247.0000 6 0001176309 Common Stock
A 2021-08-09   ORAMED PHARMACEUTICALS INC. 4 M-Exempt --D 10000.0000 34224.0000 5 0001176309 Common Stock
D 2021-08-09   ORAMED PHARMACEUTICALS INC. 4 F-InKind --D 1517.0000 24224.0000 4 0001176309 Common Stock
A 2021-08-09   ORAMED PHARMACEUTICALS INC. 4 M-Exempt --D 6666.0000 25741.0000 3 0001176309 Common Stock
D 2021-08-09   ORAMED PHARMACEUTICALS INC. 4 F-InKind --D 1683.0000 19075.0000 2 0001176309 Common Stock
A 2021-08-09   ORAMED PHARMACEUTICALS INC. 4 M-Exempt --D 5697.0000 20758.0000 1 0001176309 Common Stock
A 2021-06-11   Quantum-Si Inc 4 A-Award --D 20512.0000 20512.0000 2 0001816431 Class A Common Stock
A 2021-06-10   Quantum-Si Inc 4 A-Award --I 1901000.0000 1901000.0000 1 0001816431 Class A Common Stock
A 2021-02-17   ORAMED PHARMACEUTICALS INC. 4 A-Award --D 15000.0000 15000.0000 1 0001176309 Stock Option (right to buy)
A 2020-01-08   ORAMED PHARMACEUTICALS INC. 4 A-Award --D 20000.0000 20000.0000 1 0001176309 Stock Option (right to buy)
A 2019-09-12   ORAMED PHARMACEUTICALS INC. 4 A-Award --D 10000.0000 10000.0000 2 0001176309 Stock Option (right to buy)
D 2019-04-10   ORAMED PHARMACEUTICALS INC. 4 D-Return --D 10000.0000 0.0000 1 0001176309 Stock Option (right to buy)
A 2019-04-10   ORAMED PHARMACEUTICALS INC. 4 A-Award --D 10000.0000 10000.0000 1 0001176309 Stock Option (right to buy)
D 2019-02-08   HISTOGENICS CORP 4 M-Exempt --I 111111.0000 0.0000 8 0001372299 Common Stock Warrant (Right to Buy)
D 2019-02-08   HISTOGENICS CORP 4 M-Exempt --I 33333.0000 0.0000 7 0001372299 Common Stock Warrant (Right to Buy)
D 2019-02-08   HISTOGENICS CORP 4 M-Exempt --I 33333.0000 0.0000 6 0001372299 Common Stock Warrant (Right to Buy)
D 2019-02-08   HISTOGENICS CORP 4 M-Exempt --D 173076.0000 0.0000 5 0001372299 Common Stock Warrant (Right to Buy)
A 2019-02-08   HISTOGENICS CORP 4 M-Exempt --I 111111.0000 257846.0000 4 0001372299 Common Stock
A 2019-02-08   HISTOGENICS CORP 4 M-Exempt --I 33333.0000 66666.0000 3 0001372299 Common Stock
A 2019-02-08   HISTOGENICS CORP 4 M-Exempt --I 33333.0000 66666.0000 2 0001372299 Common Stock
A 2019-02-08   HISTOGENICS CORP 4 M-Exempt --D 173076.0000 418639.0000 1 0001372299 Common Stock
A 2018-10-10   HISTOGENICS CORP 4 P-Purchase --D 173076.0000 173076.0000 5 0001372299 Common Stock Warrant (Right to Buy)
A 2018-10-10   HISTOGENICS CORP 4 P-Purchase --D 230768.0000 245563.0000 1 0001372299 Common Stock
A 2018-06-15   HISTOGENICS CORP 4 A-Award --D 25000.0000 25000.0000 1 0001372299 Stock Option (Right to Buy)
A 2017-06-30   ORAMED PHARMACEUTICALS INC. 4 A-Award --D 56773.0000 56773.0000 1 0001176309 Stock Option (right to buy)
A 2017-06-13   HISTOGENICS CORP 4 A-Award --D 25000.0000 25000.0000 1 0001372299 Stock Option (Right to Buy)
A 2017-02-09   ORAMED PHARMACEUTICALS INC. 4 A-Award --D 5697.0000 5697.0000 1 0001176309 Stock Option (right to buy)
A 2016-12-16   HISTOGENICS CORP 4 A-Award --D 10000.0000 10000.0000 1 0001372299 Stock Option (Right to Buy)
A 2016-12-06   ORAMED PHARMACEUTICALS INC. 4 A-Award --D 3300.0000 15061.0000 2 0001176309 Common Stock
A 2016-12-05   ORAMED PHARMACEUTICALS INC. 4 A-Award --D 2300.0000 11761.0000 1 0001176309 Common Stock
A 2016-12-02   ORAMED PHARMACEUTICALS INC. 4 A-Award --D 7261.0000 9461.0000 2 0001176309 Common Stock
A 2016-12-01   ORAMED PHARMACEUTICALS INC. 4 A-Award --D 2200.0000 2200.0000 1 0001176309 Common Stock
D 2016-11-30   HISTOGENICS CORP 4 C-Conversion --I 200.2455 0.0000 6 0001372299 Series A Convertible Preferred Stock
D 2016-11-30   HISTOGENICS CORP 4 C-Conversion --I 60.0728 0.0000 5 0001372299 Series A Convertible Preferred Stock
D 2016-11-30   HISTOGENICS CORP 4 C-Conversion --I 60.0728 0.0000 4 0001372299 Series A Convertible Preferred Stock
A 2016-11-30   HISTOGENICS CORP 4 C-Conversion --I 88998.0000 228196.0000 3 0001372299 Common Stock
A 2016-11-30   HISTOGENICS CORP 4 C-Conversion --I 26699.0000 139198.0000 2 0001372299 Common Stock
A 2016-11-30   HISTOGENICS CORP 4 C-Conversion --I 26699.0000 112499.0000 1 0001372299 Common Stock
D 2016-09-29   HISTOGENICS CORP 4 A-Award --I 111111.0000 177777.0000 9 0001372299 Common Stock Warrant (Right to Buy)
D 2016-09-29   HISTOGENICS CORP 4 A-Award --I 33333.0000 66666.0000 8 0001372299 Common Stock Warrant (Right to Buy)
D 2016-09-29   HISTOGENICS CORP 4 A-Award --I 33333.0000 33333.0000 7 0001372299 Common Stock Warrant (Right to Buy)
D 2016-09-29   HISTOGENICS CORP 4 A-Award --I 200.2455 320.3911 6 0001372299 Series A Convertible Preferred Stock
D 2016-09-29   HISTOGENICS CORP 4 A-Award --I 60.0728 120.1456 5 0001372299 Series A Convertible Preferred Stock
D 2016-09-29   HISTOGENICS CORP 4 A-Award --I 60.0728 60.0728 4 0001372299 Series A Convertible Preferred Stock
A 2016-09-29   HISTOGENICS CORP 4 A-Award --I 22113.0000 85800.0000 3 0001372299 Common Stock
A 2016-09-29   HISTOGENICS CORP 4 A-Award --I 6634.0000 63687.0000 2 0001372299 Common Stock
A 2016-09-29   HISTOGENICS CORP 4 A-Award --I 6634.0000 57053.0000 1 0001372299 Common Stock
A 2015-06-24   HISTOGENICS CORP 4 A-Award --D 20000.0000 20000.0000 1 0001372299 Stock Option (Right to Buy)
D 2014-12-08   HISTOGENICS CORP 4 X-InTheMoney --D 242.0000 0.0000 13 0001372299 Common Stock Warrant (Right to Buy)
D 2014-12-08   HISTOGENICS CORP 4 C-Conversion --I 3914.0000 0.0000 15 0001372299 Series A-1 Preferred Stock
D 2014-12-08   HISTOGENICS CORP 4 C-Conversion --I 6444.0000 0.0000 14 0001372299 Series A Preferred Stock
D 2014-12-08   HISTOGENICS CORP 4 C-Conversion --D 5871.0000 0.0000 12 0001372299 Series A-1 Preferred Stock
D 2014-12-08   HISTOGENICS CORP 4 C-Conversion --D 9667.0000 0.0000 11 0001372299 Series A Preferred Stock
D 2014-12-08   HISTOGENICS CORP 4 J-Other --I 58.0000 50420.0000 10 0001372299 Common Stock
A 2014-12-08   HISTOGENICS CORP 4 P-Purchase --I 4495.0000 50478.0000 9 0001372299 Common Stock
A 2014-12-08   HISTOGENICS CORP 4 C-Conversion --D 5871.0000 28747.0000 2 0001372299 Common Stock

http://www.sec.gov/cgi-bin/own-disp

Home | Search Home | Previous Page
Modified: 04/22/2016